NCI/X
Dec 19, 2024, 07:16
Major Changes in NCI ACE Award: Removal of Citizenship Requirements and Eligibility Limitations
Anirban Maitra shared a post on X:
“The two most important changes that are coming to National Cancer Institute training grant mechanism for postdoctoral fellows (now called K32 or Academic Career Excellence (ACE) Award) are:
- REMOVAL of citizenship requirements (this is huge)
- Limiting eligibility to 1st two years of fellowship.
The companion notices are pasted below:
- Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 – Independent Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 – Independent Clinical Trial Required)“
Dr. Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 15, 2025, 15:57
Jan 15, 2025, 15:20
Jan 15, 2025, 15:18
Jan 15, 2025, 15:12
Jan 15, 2025, 15:10
Jan 15, 2025, 15:06
Jan 15, 2025, 14:33